Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Puretech Health Plc ADR
(NQ:
PRTC
)
27.64
-1.15 (-3.99%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Puretech Health Plc ADR
< Previous
1
2
3
4
5
6
7
Next >
PureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 Results
April 13, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces American Journal of Psychiatry Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Disorder When Combined w/ Antidepressant Medication
April 12, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Announces Publication of Research from Collaborators Demonstrating PureTech’s Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy)
April 12, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Results
April 07, 2022
From
PureTech Health
Via
Business Wire
Drug makers, Scientists Working For Long COVID Treatments: Reuters
March 25, 2022
Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,
Via
Benzinga
PureTech Appoints Sharon Barber-Lui to Board of Directors & Audit Committee
March 24, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product Officer
March 17, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
March 16, 2022
From
PureTech Health plc
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
March 09, 2022
During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...
Via
Benzinga
PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning
February 17, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
February 15, 2022
From
PureTech Health
Via
Business Wire
PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 10, 2022
From
PureTech Health
Via
Business Wire
PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms
January 31, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
January 26, 2022
From
PureTech Health plc
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
January 21, 2022
Gainers Biophytis (NASDAQ:BPTS) shares rose 12.3% to $5.28 during Friday's regular session. The market value of their outstanding shares is at $68.0 million. Intra-...
Via
Benzinga
Gelesis, Maker Of Weight Loss Pill, Concludes SPAC Deal; Trading Kickstarts Today
January 14, 2022
PureTech Health plc (NASDAQ: PRTC) founded entity Gelesis Inc, maker of weight management aid, has completed its business combination with Capstar Special...
Via
Benzinga
PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar
January 14, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at 40th Annual J.P. Morgan Healthcare Conference
January 07, 2022
From
PureTech Health plc
Via
Business Wire
PureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidone
January 06, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis Appoints Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee
January 05, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Provides End of Year Report on Key Progress Across Wholly Owned Programs and Founded Entities
December 16, 2021
From
PureTech Health
Via
Business Wire
PureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological Conditions
December 08, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological Conditions
December 07, 2021
From
PureTech Health plc
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
December 02, 2021
Gainers Biofrontera (NASDAQ:BFRI) shares ...
Via
Benzinga
PureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer
December 01, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from Ro
November 18, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing Updates
November 16, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces Participation in Two Upcoming Investor Conferences
November 15, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 12, 2021
From
PureTech Health plc
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.